Ascension Seton Medical Center
- Type
- Teaching hospital
- Where
- Austin, TX
- Medicare CCN
- 450056
- Received
- $682,138 in 246 records, 2024 ($140,105 general, $542,033 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: ASCENSION SETON MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 30 | $140,105 |
| 2024 | Research payment | 216 | $542,033 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| United Therapeutics Corporation | 21 | $132,953 | 2024 |
| Abbott Laboratories | 26 | $113,822 | 2024 |
| Bolton Medical Inc | 42 | $66,234 | 2024 |
| Medtronic, Inc. | 20 | $55,789 | 2024 |
| Penumbra, Inc. | 14 | $54,780 | 2024 |
| AngioDynamics, Inc. | 2 | $43,000 | 2024 |
| Janssen Research & Development, LLC | 21 | $31,285 | 2024 |
| Impulse Dynamics (USA) Inc. | 19 | $25,974 | 2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $25,360 | 2024 |
| Alexion Pharmaceuticals, Inc. | 2 | $24,004 | 2024 |
| BIOTRONIK INC. | 42 | $23,691 | 2024 |
| Orthofix Medical, Inc. | 2 | $19,000 | 2024 |
| Aimmune Therapeutics, Inc. | 2 | $15,069 | 2024 |
| GENZYME CORPORATION | 1 | $14,700 | 2024 |
| Stryker Corporation | 6 | $12,692 | 2024 |
| Mylan Specialty L.P. | 2 | $6,200 | 2024 |
| LEICA MICROSYSTEMS INC. | 3 | $5,075 | 2024 |
| Applied Medical Resources Corporation | 1 | $3,607 | 2024 |
| CashFlow Solutions, LLC | 1 | $3,156 | 2024 |
| Veryan Medical Incorporated | 6 | $2,887 | 2024 |
| Philips North America LLC | 1 | $2,000 | 2024 |
| Merge Healthcare Incorporated | 8 | $705 | 2024 |
| Aesculap, Inc. | 1 | $146 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 216 | $542,033 |
| Long term medical supply or device loan | 7 | $51,469 |
| Space rental or facility fees (teaching hospital only) | 8 | $44,009 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 3 | $22,300 |
| Debt forgiveness | 3 | $18,012 |
| Education | 1 | $3,607 |
| Food and Beverage | 8 | $705 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | AngioDynamics, Inc. | $30,000 | Long term medical supply or device loan | In-kind items and services | Auryon Laser System 100-120 Vac Device, ET | 2024 | |
| 2024-12-31 | AngioDynamics, Inc. | $13,000 | Long term medical supply or device loan | In-kind items and services | Solero Device, Oncology | 2024 | |
| 2024-12-31 | Stryker Corporation | $237 | Long term medical supply or device loan | In-kind items and services | NA Device, PATIENT HANDLING - PH | 2024 | |
| 2024-12-31 | Stryker Corporation | $204 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-12-27 | Stryker Corporation | $9,500 | Research payment | Cash or cash equivalent | YUKON OCT SPINAL SYSTEM Device, SPINE | COMPASS | 2024 |
| 2024-12-27 | Stryker Corporation | $1,500 | Research payment | Cash or cash equivalent | YUKON OCT SPINAL SYSTEM Device, SPINE | COMPASS | 2024 |
| 2024-12-27 | Stryker Corporation | $750 | Research payment | Cash or cash equivalent | YUKON OCT SPINAL SYSTEM Device, SPINE | COMPASS | 2024 |
| 2024-12-27 | Stryker Corporation | $500 | Research payment | Cash or cash equivalent | YUKON OCT SPINAL SYSTEM Device, SPINE | COMPASS | 2024 |
| 2024-12-23 | Janssen Research & Development, LLC | $470 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-12-23 | Janssen Research & Development, LLC | $239 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-12-23 | Janssen Research & Development, LLC | $239 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-12-23 | Janssen Research & Development, LLC | $231 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-12-20 | BIOTRONIK INC. | $250 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-12-17 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-12-17 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-12-16 | Medtronic, Inc. | $2,366 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2024 |
| 2024-12-09 | Penumbra, Inc. | $2,917 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-12-05 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-12-05 | BIOTRONIK INC. | $134 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-12-05 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-12-03 | Merge Healthcare Incorporated | $14 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-12-02 | Abbott Laboratories | $431 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-12-02 | Merge Healthcare Incorporated | $253 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-11-30 | Bolton Medical Inc | $1,500 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-11-28 | Janssen Research & Development, LLC | $500 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-11-22 | United Therapeutics Corporation | $3,478 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-11-22 | Merge Healthcare Incorporated | $53 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-11-22 | Merge Healthcare Incorporated | $23 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-11-19 | Merge Healthcare Incorporated | $103 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-11-14 | Janssen Research & Development, LLC | $1,032 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-11-13 | Abbott Laboratories | $14,818 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Cand | 2024 |
| 2024-11-07 | Abbott Laboratories | $60 | Research payment | In-kind items and services | NAVITOR Device, VASCULAR | Envision IDE | 2024 |
| 2024-11-06 | Alexion Pharmaceuticals, Inc. | $12,873 | Research payment | Cash or cash equivalent | This is a US observational registry of pediatric NF1 PN participants treated with selumetinib. | 2024 | |
| 2024-11-06 | Abbott Laboratories | $8,097 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, STRUCTURAL HEART | AMPLATZER PFO Occluder Post Approval Study (PFO PAS) | 2024 |
| 2024-11-06 | Impulse Dynamics (USA) Inc. | $248 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-11-05 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-11-05 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-11-01 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-11-01 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-11-01 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-11-01 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-10-29 | Philips North America LLC | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | (4137) MR systems OEM Device, Medical Device | 2024 | |
| 2024-10-29 | Mylan Specialty L.P. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-10-22 | Abbott Laboratories | $9,250 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2024 |
| 2024-10-22 | Mylan Specialty L.P. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-10-22 | Abbott Laboratories | $3,200 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2024 |
| 2024-10-22 | Abbott Laboratories | $175 | Research payment | In-kind items and services | MITRACLIP Device, STRUCTURAL HEART | REPAIR MR | 2024 |
| 2024-10-21 | United Therapeutics Corporation | $1,095 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-10-15 | Penumbra, Inc. | $2,779 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-10-10 | Impulse Dynamics (USA) Inc. | $4,961 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-10-09 | Bolton Medical Inc | $1,200 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-10-07 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-10-07 | Janssen Research & Development, LLC | $239 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-10-07 | Janssen Research & Development, LLC | $239 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-10-07 | Janssen Research & Development, LLC | $207 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-10-04 | BIOTRONIK INC. | $286 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-10-04 | BIOTRONIK INC. | $286 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-10-04 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-10-04 | BIOTRONIK INC. | $134 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-10-04 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-27 | Bolton Medical Inc | $300 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-26 | Bolton Medical Inc | $1,007 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-25 | United Therapeutics Corporation | $9,727 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-09-19 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-19 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-19 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-19 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-19 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-17 | Abbott Laboratories | $7,750 | Research payment | Cash or cash equivalent | NAVITOR Device, VASCULAR | Envision IDE Study | 2024 |
| 2024-09-17 | Abbott Laboratories | $1,200 | Research payment | Cash or cash equivalent | NAVITOR Device, VASCULAR | Envision IDE Study | 2024 |
| 2024-09-13 | United Therapeutics Corporation | $2,000 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-09-09 | Penumbra, Inc. | $6,738 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-09-05 | Bolton Medical Inc | $7,250 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | EXTEND | 2024 |
| 2024-09-05 | Bolton Medical Inc | $1,614 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-05 | Bolton Medical Inc | $841 | Research payment | Cash or cash equivalent | RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-09-05 | Merge Healthcare Incorporated | $24 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-09-04 | Merge Healthcare Incorporated | $124 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-08-31 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-31 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-31 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-31 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-31 | Veryan Medical Incorporated | $544 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-08-31 | Bolton Medical Inc | $300 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-30 | Orthofix Medical, Inc. | $500 | Research payment | Cash or cash equivalent | M6-C Device, Prosthesis, Intervertebral Disc | CA-C003 - M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study | 2024 |
| 2024-08-28 | LEICA MICROSYSTEMS INC. | $2,573 | Long term medical supply or device loan | In-kind items and services | SENTIMAG Device, Devices | 2024 | |
| 2024-08-28 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-28 | LEICA MICROSYSTEMS INC. | $1,251 | Long term medical supply or device loan | In-kind items and services | SENTIMAG Device, Devices | 2024 | |
| 2024-08-28 | LEICA MICROSYSTEMS INC. | $1,251 | Long term medical supply or device loan | In-kind items and services | SENTIMAG Device, Devices | 2024 | |
| 2024-08-28 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-08-27 | United Therapeutics Corporation | $450 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-08-26 | Medtronic, Inc. | $2,500 | Research payment | Cash or cash equivalent | SYMPLICITY G3 Device, Renal Denervation System | SPYRAL AFFIRM | 2024 |
| 2024-08-21 | United Therapeutics Corporation | $5,052 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-08-19 | Abbott Laboratories | $12,444 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, STRUCTURAL HEART | AMPLATZER PFO Occluder Post Approval Study | 2024 |
| 2024-08-16 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-08-16 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-08-16 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-08-14 | VERTEX PHARMACEUTICALS INCORPORATED | $20,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-08-14 | Abbott Laboratories | $8,866 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2024 |
| 2024-08-14 | United Therapeutics Corporation | $3,000 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-08-14 | Veryan Medical Incorporated | $500 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-08-13 | Medtronic, Inc. | $2,850 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2024 |
| 2024-08-12 | Penumbra, Inc. | $6,064 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-08-08 | Abbott Laboratories | $2,000 | Research payment | Cash or cash equivalent | NAVITOR Device, VASCULAR | Envision IDE Study | 2024 |
| 2024-08-07 | Impulse Dynamics (USA) Inc. | $5,125 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-08-07 | Abbott Laboratories | $188 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | AVEIR Device, Cardiac Rhythm Management | 2024 | |
| 2024-08-07 | Abbott Laboratories | $188 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | AVEIR Device, Cardiac Rhythm Management | 2024 | |
| 2024-08-05 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-08-05 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-08-05 | Janssen Research & Development, LLC | $446 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-07-31 | BIOTRONIK INC. | $17,661 | Debt forgiveness | Cash or cash equivalent | Intica Neo 7 HF-T DF-1 IS-1 ProMRI Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-07-29 | Medtronic, Inc. | $81 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2024 |
| 2024-07-29 | Medtronic, Inc. | $81 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2024 |
| 2024-07-26 | United Therapeutics Corporation | $5,509 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-07-24 | Veryan Medical Incorporated | $558 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-07-24 | Veryan Medical Incorporated | $558 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-07-24 | Veryan Medical Incorporated | $558 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-07-24 | Veryan Medical Incorporated | $165 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2024 |
| 2024-07-22 | Penumbra, Inc. | $103 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-07-19 | Penumbra, Inc. | $103 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-07-17 | Aesculap, Inc. | $146 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-07-16 | Impulse Dynamics (USA) Inc. | $3,806 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-07-15 | Penumbra, Inc. | $1,000 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-07-11 | Penumbra, Inc. | $100 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-07-08 | Janssen Research & Development, LLC | $5,200 | Research payment | Cash or cash equivalent | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2024 | |
| 2024-07-01 | United Therapeutics Corporation | $754 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-06-24 | United Therapeutics Corporation | $10,029 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-06-21 | Orthofix Medical, Inc. | $18,500 | Research payment | Cash or cash equivalent | M6-C Device, Prosthesis, Intervertebral Disc | CA-C003 - M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study | 2024 |
| 2024-06-18 | Medtronic, Inc. | $248 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
| 2024-06-17 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2024 |
| 2024-06-17 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2024 |
| 2024-06-14 | United Therapeutics Corporation | $1,642 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-06-14 | Penumbra, Inc. | $1,305 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-06-11 | Impulse Dynamics (USA) Inc. | $248 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-06-06 | Medtronic, Inc. | $541 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2024 |
| 2024-06-05 | United Therapeutics Corporation | $2,425 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-06-04 | Aimmune Therapeutics, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2024 | |
| 2024-06-04 | Abbott Laboratories | $11,500 | Research payment | Cash or cash equivalent | NAVITOR Device, VASCULAR | Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, | 2024 |
| 2024-05-28 | Medtronic, Inc. | $1,700 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
| 2024-05-28 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
| 2024-05-22 | Impulse Dynamics (USA) Inc. | $2,025 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-05-22 | Impulse Dynamics (USA) Inc. | $1,750 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-05-22 | Medtronic, Inc. | $248 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
| 2024-05-22 | Impulse Dynamics (USA) Inc. | $207 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-05-20 | Janssen Research & Development, LLC | $15,104 | Research payment | Cash or cash equivalent | STELARA Biological, Immunology | Open-label Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Ustekinumab in Pediatric Participants | 2024 |
| 2024-05-20 | Janssen Research & Development, LLC | $2,500 | Research payment | Cash or cash equivalent | TREMFYA Drug, Immunology | A Study to Evaluate the Efficacy Safety and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment | 2024 |
| 2024-05-17 | United Therapeutics Corporation | $5,967 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-05-13 | Abbott Laboratories | $1,453 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, STRUCTURAL HEART | AMPLATZER PFO Occluder Post Approval Study (PFO PAS) | 2024 |
| 2024-05-10 | United Therapeutics Corporation | $4,161 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-05-10 | Penumbra, Inc. | $1,932 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-05-10 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-05-10 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-05-10 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-05-10 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-05-10 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-05-09 | CashFlow Solutions, LLC | $3,156 | Long term medical supply or device loan | In-kind items and services | LYMPHA PRESS OPTIMAL PLUS(US) BT Device, Pneumatic Compressor | 2024 | |
| 2024-05-06 | Abbott Laboratories | $10,435 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Cand | 2024 |
| 2024-05-02 | Applied Medical Resources Corporation | $3,607 | Education | In-kind items and services | GelPOINT Mini Advanced Access Platform Device, SPECIALTY ACCESS | 2024 | |
| 2024-05-02 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, STRUCTURAL HEART | AMPLATZER PFO Occluder Post Approval Study (PFO PAS) | 2024 |
| 2024-04-23 | Merge Healthcare Incorporated | $107 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2024 | |
| 2024-04-22 | Medtronic, Inc. | $2,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | STEALTHSTATION S8 PLATFORM Device, Image Guided Surgery Products | 2024 | |
| 2024-04-18 | Medtronic, Inc. | $2,500 | Research payment | Cash or cash equivalent | SYMPLICITY G3 Device, Renal Denervation System | SPYRAL AFFIRM | 2024 |
| 2024-04-17 | United Therapeutics Corporation | $5,907 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-04-17 | Impulse Dynamics (USA) Inc. | $1,713 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-04-17 | BIOTRONIK INC. | $500 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2024 |
| 2024-04-17 | Penumbra, Inc. | $500 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-04-16 | Bolton Medical Inc | $1,250 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-04-16 | Abbott Laboratories | $140 | Research payment | In-kind items and services | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Cand | 2024 |
| 2024-04-15 | Medtronic, Inc. | $4,500 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
| 2024-04-13 | Impulse Dynamics (USA) Inc. | $500 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-04-12 | United Therapeutics Corporation | $10,085 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-04-10 | Penumbra, Inc. | $5,821 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-04-03 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-04-03 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-04-03 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-04-03 | Bolton Medical Inc | $828 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-03-26 | Impulse Dynamics (USA) Inc. | $207 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-03-25 | United Therapeutics Corporation | $16,858 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2024 | |
| 2024-03-25 | GENZYME CORPORATION | $14,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | THYMOGLOBULIN Biological, Oncology | 2024 | |
| 2024-03-21 | Bolton Medical Inc | $1,863 | Research payment | Cash or cash equivalent | TREO ABDOMINAL STENT-GRAFT SYSTEM Device, ENDOVASCULAR AORTIC REPAIR | TIGER PAS | 2024 |
| 2024-03-21 | Abbott Laboratories | $1,250 | Research payment | Cash or cash equivalent | MITRACLIP Device, STRUCTURAL HEART | Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Cand | 2024 |
| 2024-03-20 | Penumbra, Inc. | $19,000 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-03-13 | Impulse Dynamics (USA) Inc. | $300 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-03-12 | Impulse Dynamics (USA) Inc. | $1,000 | Research payment | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | 2024 |
| 2024-03-12 | Medtronic, Inc. | $860 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2024 |
| 2024-03-07 | Penumbra, Inc. | $6,413 | Research payment | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | STORM-PE | 2024 |
| 2024-03-01 | Medtronic, Inc. | $11,923 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2024 |
The latest 200 records of 246.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Austin, TX, county Travis County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Austin, TX | County Travis County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 979,539 | 1,330,015 | 30,188,424 |
| Population, 2020 census P1 | 961,855 | 1,290,188 | 29,145,505 |
| Median age B01002 | 34.7 | 35.6 | 35.6 |
| Under 18 B01001 | 18.0% | 20.2% | 25.0% |
| 65 and over B01001 | 10.4% | 11.0% | 13.4% |
| Households B11001 | 456,113 | 583,747 | 10,992,816 |
| Foreign born B05002 | 18.7% | 18.1% | 17.6% |
| Median household income B19013 | $93,658 | $99,611 | $78,476 |
| Median family income B19113 | $128,808 | $131,256 | $94,599 |
| Per capita income B19301 | $62,862 | $62,607 | $40,752 |
| Poverty rate B17001 | 12.0% | 10.9% | 13.8% |
| Unemployment rate B23025 | 4.7% | 4.6% | 5.3% |
| Civilian labor force B23025 | 617,774 | 799,524 | 15,233,563 |
| Mean commute (minutes) B08013 | 23.7 | 25.2 | 26.7 |
| Bachelor's degree or higher B15003 | 59.6% | 56.6% | 33.8% |
| Housing units B25001 | 483,071 | 618,236 | 12,128,515 |
| Owner-occupied B25003 | 43.4% | 52.1% | 62.6% |
| Renters B25003 | 56.6% | 47.9% | 37.4% |
| Median home value B25077 | $555,300 | $523,000 | $283,800 |
| Median gross rent B25064 | $1,729 | $1,744 | $1,403 |
| White, not Hispanic B03002 | 47.0% | 46.9% | 39.1% |
| Black B03002 | 7.3% | 7.8% | 11.9% |
| Hispanic or Latino B03002 | 31.9% | 32.6% | 39.7% |
| Asian B03002 | 9.0% | 7.8% | 5.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Austin, TX.
Comments